Use of pharmacological data for bioavailability and pharmacokinetic analyses
โ Scribed by Paul A. Kramer
- Publisher
- John Wiley and Sons
- Year
- 1977
- Tongue
- English
- Weight
- 486 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Vigabatrin (VGB), an irreversible inhibitor of GABA, is being developed as an add-on therapy for uncontrolled complex partial seizure. A single-dose study was conducted in three groups of subjects with normal, mild-to-moderate, and moderate-to-severe renal impairment to examine the effect of renal f
Pharmacokinetic studies in mice traditionally require one animal per time point, resulting in dosing and euthanizing a large number of animals and producing suboptimal quality of pharmacokinetic data due to inter-animal variability and dosing error. These studies are time-consuming and labor-intensi
A computer aided method for selecting drugs as potential candidates for oral prolonged release formulations has been previously published. In order to decide whether trial formulations were warranted, prolonged release dosing was simulated to find all release rates and doses producing successful reg